title: Monitoring of methotrexate and reduced folates in the cerebrospinal fluid of cancer patients.
authors.affiliation: Institute of Pharmacy, Department of Clinical Pharmacy, Rheinische Friedrich-Wilhelms-Universität Bonn, Germany.
authors.forename: S
authors.initials: S
authors.lastname: Vezmar
authors.forename: U
authors.initials: U
authors.lastname: Bode
authors.forename: U
authors.initials: U
authors.lastname: Jaehde
mesh_terms: D002851:Chromatography, High Pressure Liquid; D016903:Drug Monitoring; D005493:Folic Acid Antagonists / Q000134:cerebrospinal fluid* / Q000627:therapeutic use; D006801:Humans; D002955:Leucovorin / Q000134:cerebrospinal fluid; D008727:Methotrexate / Q000134:cerebrospinal fluid* / Q000627:therapeutic use; D009369:Neoplasms / Q000134:cerebrospinal fluid* / Q000188:drug therapy; D013763:Tetrahydrofolates / Q000134:cerebrospinal fluid*
chemical_list: D005493:Folic Acid Antagonists; D013763:Tetrahydrofolates; C013123:5,10-methylenetetrahydrofolic acid; D002955:Leucovorin; C005984:5-methyltetrahydrofolate; D008727:Methotrexate